Pharmageek

PARIS - Un projet de décret dont APMnews/TICsanté a obtenu copie détaille le fonctionnement d'un système d'information (SI) de suivi de la vaccination contre le Sars-CoV-2, baptisé "Vaccin Covid".

Lire l'article complet sur : www.ticsante.com

Translations: ελληνικά / عربى / 中文 / 粵文 / Deutsch / Español / Français / עִברִית / עִברִית2 / Hrvatski / Italiano / नेपाली / Polskie / русский / Português. / Markdown for translating

Welcome! In this post, we’ll be taking a character-by-character look at the source code of the BioNTech/Pfizer SARS-CoV-2 mRNA vaccine.

I want to thank the large cast of people who spent time previewing this article for legibility and correctness.

Lire l'article complet sur : berthub.eu

The Covid-19 pandemic has tested society as a whole and made an undeniable impact on healthcare across all care settings, while at the same time illuminating ways the industry must improve moving forward. The strain the virus has placed on care delivery serves as an opportunity for both reflection and growth, as we look to advance our public health infrastructure.

Lessons Learned from Covid-19

Regarding advance care planning, Covid-19 provided everyone with a rare example of why it is so vital to communicate end-of-life wishes in a clear and easily accessible way. It also exposed the greater need for providers to proactively engage in these discussions with patients and their loved ones as a critical component to achieving patient-centric value-based care.
Walmart pharmacies fueled opioid crisis, DOJ lawsuit claims

The pandemic has also highlighted the importance and the shortage of palliative care providers in the U.S. With the sudden surge of patients overwhelming EDs, some hospitals have responded by embedding palliative care physicians in the ED, leveraging their expertise in conducting goals-of-care conversations to provide their patients with increased access to goal-concordant care. Some have leveraged additional palliative care support through telehealth, as their onsite clinicians found themselves unable to keep up with demand. Palliative care will continue to be in high demand during the pandemic and beyond, and there will need to be a strong effort to drive more providers into the field.

Lire l'article complet sur : medcitynews.com

Remote-monitoring startup BioIntelliSense received funding from the U.S. Army Medical Research and Development Command (USAMRDC) to see if its wearable sensor “sticker” could be used to detect Covid-19 symptoms early. The Golden, Colo.-based startup, and Royal Philips (NYSE: PHG), received a $2.8 million award to use wearable to identify Covid-19 cases before symptoms appear.

BioIntelliSense received FDA clearance a year ago for a small, adhesive sensor it developed that can monitor a patient’s heart rate, respiratory rate and skin temperature, as well as their gait, body position or coughing. At the beginning of 2020, it struck a partnership with Colorado-based health system UCHealth to use its device leading up to a surgery or for postoperative care.

Now, the companies plan to enroll 2,500 patients into a study, working with the University of Colorado Anschutz Medical Campus, to validate the startup’s BioSticker device for early symptom detection. People who are experiencing Covid-19 symptoms or who had a recent exposure to the disease are eligible to participate.

Lire l'article complet sur : medcitynews.com